stockrowIonis Pharmaceuticals, Inc. (IONS) vs Mirum Pharmaceuticals, Inc. (MIRM)
- Ionis Pharmaceuticals, Inc. IONS 39.48 +1.75%
- Mirum Pharmaceuticals, Inc. MIRM 93.82 +0.30%
Ionis Pharmaceuticals, Inc. and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Ionis Pharmaceuticals, Inc. and Mirum Pharmaceuticals, Inc. are of similar size ($6.5B and $6.1B). Mirum Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 42.2% against −7.41%. Ionis Pharmaceuticals, Inc. has the higher net margin (−64.7% vs −134.8%) and the higher return on invested capital (0.00% vs −184.7%). Across the 16 metrics below, Ionis Pharmaceuticals, Inc. leads on 10 and Mirum Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | IONS | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.17% | 81.72% | 65.16% |
| Operating margin | (68.00%) | (133.62%) | 0.00% |
| Net margin | (64.66%) | (134.75%) | 0.00% |
| Free cash flow margin | (64.93%) | (46.04%) | 0.00% |
| Return on equity | (105.50%) | (760.01%) | (50.12%) |
| Return on assets | (18.90%) | (99.78%) | (45.60%) |
| Return on invested capital | 0.00% | (184.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack